BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2906412)

  • 1. [Bopindolol in the treatment of mild and moderate arterial hypertension].
    Monaci R; Morganti G; Cecchin A; Morandini M
    Minerva Cardioangiol; 1988 Oct; 36(10):495-7. PubMed ID: 2906412
    [No Abstract]   [Full Text] [Related]  

  • 2. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-blockers in the treatment of hypertension in elderly patients].
    Lefflerová K; Widimský J; Lupínek Z
    Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihypertensive effect of atenolol and bopindolol in the elderly.
    Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
    Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
    Zsáry A; Káldi N; Kállay K
    Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bopindolol versus metoprolol in hypertension.
    Westerman RF; Christensen C; Westheim A; Donker AJ
    Eur J Clin Pharmacol; 1986; 31(3):379-80. PubMed ID: 2878814
    [No Abstract]   [Full Text] [Related]  

  • 9. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
    Abetel G
    Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
    [No Abstract]   [Full Text] [Related]  

  • 12. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW; Goa KL; Langtry HD
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
    Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipid fractions during bopindolol treatment in hypertensive patients.
    van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with the use of a beta-blocking agent in the community treatment of arterial hypertension].
    Bucci A; Catalucci AM; Giampaoli S
    Clin Ter; 1981 Jun; 97(5):521-7. PubMed ID: 6115733
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with bopindolol: summary of poster presentations.
    Ikeda M; Nakashima Y
    Am J Cardiol; 1991 Apr; 67(10):47B-50B. PubMed ID: 1673582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.